Publication
Article
Pharmacy Times
The results of a recent study indicate that patients with asthma cannot reduce their risk of developing the common cold by taking vitamin D supplements.
The results of a recent study indicate that patients with asthma cannot reduce their risk of developing the common cold by taking vitamin D supplements. The study, published in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine, randomly assigned 408 patients, with mild to moderate asthma, to receive either vitamin D supplementation (100,000 IU once, followed by 4000 IU daily) or placebo for 28 weeks. The research team found that the achievement of vitamin D sufficiency among patients who received the supplements made no difference in either the number or the severity of colds compared with those who were given placebo; in fact, African-American participants, who received vitamin D supplements, experienced more colds than those in the placebo group.
The researchers were surprised by these results, as they had previously published a study in which the achievement of vitamin D sufficiency, among deficient patients, was associated with a 40% reduction in asthma exacerbations. One possible explanation the authors gave for their latest finding was that patients with asthma who had low vitamin D levels are more likely to experience an inflammatory response triggered by upper respiratory infections; this response could then reduce the risk of lower airway infections.
Although the study authors noted a number of benefits associated with the use of vitamin D in patients with asthma, they maintained that supplementation with the vitamin should not be recommended for the prevention of colds.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.